{"id":"https://openalex.org/W2093501573","doi":"https://doi.org/10.1093/jac/30.suppl_a.123","title":"A phase I, double-blind, placebo-controlled study of the tolerance and pharmacokinetic behaviour of RP 59500","display_name":"A phase I, double-blind, placebo-controlled study of the tolerance and pharmacokinetic behaviour of RP 59500","publication_year":1992,"publication_date":"1992-01-01","ids":{"openalex":"https://openalex.org/W2093501573","doi":"https://doi.org/10.1093/jac/30.suppl_a.123","mag":"2093501573","pmid":"https://pubmed.ncbi.nlm.nih.gov/1399944"},"language":"en","primary_location":{"id":"doi:10.1093/jac/30.suppl_a.123","doi":"https://doi.org/10.1093/jac/30.suppl_a.123","is_oa":false,"landing_page_url":"https://doi.org/10.1093/jac/30.suppl_a.123","pdf_url":null,"source":{"id":"https://openalex.org/S124275759","display_name":"Journal of Antimicrobial Chemotherapy","issn_l":"0305-7453","issn":["0305-7453","1460-2091"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Antimicrobial Chemotherapy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5104455891","display_name":"S. D. Etienne","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S. D. Etienne","raw_affiliation_strings":["Recherche Clinique, Rh\u00f4ne-Poulenc Rorer, Recherche et D\u00e9veloppement, Antony, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Recherche Clinique, Rh\u00f4ne-Poulenc Rorer, Recherche et D\u00e9veloppement, Antony, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054510375","display_name":"Guy Montay","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G. Montay","raw_affiliation_strings":["Institut de Biopharmacie Rh\u00f4ne-Poulenc Rorer, Recherche et D\u00e9veloppement, 92160 Antony, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut de Biopharmacie Rh\u00f4ne-Poulenc Rorer, Recherche et D\u00e9veloppement, 92160 Antony, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006671613","display_name":"Aim\u00e9 Le Liboux","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. Le Liboux","raw_affiliation_strings":["Institut de Biopharmacie Rh\u00f4ne-Poulenc Rorer, Recherche et D\u00e9veloppement, 92160 Antony, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut de Biopharmacie Rh\u00f4ne-Poulenc Rorer, Recherche et D\u00e9veloppement, 92160 Antony, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056568797","display_name":"Armand M. Frydman","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. Frydman","raw_affiliation_strings":["Institut de Biopharmacie Rh\u00f4ne-Poulenc Rorer, Recherche et D\u00e9veloppement, 92160 Antony, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut de Biopharmacie Rh\u00f4ne-Poulenc Rorer, Recherche et D\u00e9veloppement, 92160 Antony, France","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5048898485","display_name":"Jean Jacques Garaud","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. J. Garaud","raw_affiliation_strings":["Recherche Clinique Rh\u00f4ne-Poulenc Rorer, Recherche et D\u00e9veloppement, 92160 Antony, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Recherche Clinique Rh\u00f4ne-Poulenc Rorer, Recherche et D\u00e9veloppement, 92160 Antony, France","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2869,"currency":"GBP","value_usd":3784},"apc_paid":null,"fwci":4.3764,"has_fulltext":false,"cited_by_count":60,"citation_normalized_percentile":{"value":0.95574351,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"30","issue":"suppl A","first_page":"123","last_page":"131"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.9926999807357788,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.9926999807357788,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11153","display_name":"Streptococcal Infections and Treatments","score":0.0017000000225380063,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10252","display_name":"Microbial Natural Products and Biosynthesis","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/2402","display_name":"Applied Microbiology and Biotechnology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/streptogramin-antibiotics","display_name":"streptogramin antibiotics","score":0.9259999990463257},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9679999947547913},{"id":"https://openalex.org/keywords/tolerability","display_name":"tolerability","score":0.7710000276565552},{"id":"https://openalex.org/keywords/adverse-effects","display_name":"adverse effects","score":0.5239999890327454},{"id":"https://openalex.org/keywords/elimination-half-life","display_name":"elimination half-life","score":0.7820000052452087},{"id":"https://openalex.org/keywords/cmax","display_name":"Cmax","score":0.7070000171661377},{"id":"https://openalex.org/keywords/intravenous-infusion","display_name":"intravenous infusion","score":0.6420000195503235},{"id":"https://openalex.org/keywords/healthy-volunteers","display_name":"healthy volunteers","score":0.6470000147819519},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.3889999985694885}],"concepts":[{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.778525173664093},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.5268477201461792},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4883422553539276},{"id":"https://openalex.org/C3020437849","wikidata":"https://www.wikidata.org/wiki/Q608510","display_name":"Double blind study","level":5,"score":0.4653293490409851},{"id":"https://openalex.org/C3019249092","wikidata":"https://www.wikidata.org/wiki/Q274493","display_name":"Antibacterial agent","level":3,"score":0.45309877395629883},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4488992691040039},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.40744394063949585},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.30892619490623474},{"id":"https://openalex.org/C2991744798","wikidata":"https://www.wikidata.org/wiki/Q608510","display_name":"Double blind","level":4,"score":0.26864808797836304},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.24062922596931458},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0686841607093811},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004338","descriptor_name":"Drug Combinations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004341","descriptor_name":"Drug Evaluation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004357","descriptor_name":"Drug Synergism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014769","descriptor_name":"Virginiamycin","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D014769","descriptor_name":"Virginiamycin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1093/jac/30.suppl_a.123","doi":"https://doi.org/10.1093/jac/30.suppl_a.123","is_oa":false,"landing_page_url":"https://doi.org/10.1093/jac/30.suppl_a.123","pdf_url":null,"source":{"id":"https://openalex.org/S124275759","display_name":"Journal of Antimicrobial Chemotherapy","issn_l":"0305-7453","issn":["0305-7453","1460-2091"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Antimicrobial Chemotherapy","raw_type":"journal-article"},{"id":"pmid:1399944","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/1399944","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of antimicrobial chemotherapy","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2090710404","https://openalex.org/W1599156586","https://openalex.org/W7098966360","https://openalex.org/W2035619832","https://openalex.org/W2043315861","https://openalex.org/W70926855","https://openalex.org/W2355516406","https://openalex.org/W1929450387","https://openalex.org/W2037576960","https://openalex.org/W2018552602"],"abstract_inverted_index":{"The":[0,27,92],"tolerance":[1],"and":[2,39,69],"pharmacokinetic":[3],"behaviour":[4],"of":[5,55,61,75,96,112,131,149,159],"a":[6,21,47],"new":[7],"injectable":[8],"streptogramin":[9],"antibiotic,":[10],"RP":[11,62,80,105,160],"59500":[12,63,81,106,161],"were":[13,30,64,130],"evaluated":[14],"on":[15],"26":[16],"healthy":[17],"male":[18],"volunteers":[19],"in":[20,162],"double-blind,":[22],"placebo-controlled,":[23],"phase":[24,163],"I":[25],"study.":[26],"doses":[28,148],"used":[29],"1.4,":[31],"2.8,":[32],"4.6,":[33],"7.0,":[34],"9.8,":[35],"12.6,":[36],"16.8,":[37],"22.4":[38],"29.4":[40],"mg/kg;":[41],"each":[42],"dose":[43],"was":[44,138],"administered":[45],"as":[46],"1":[48],"h":[49],"infusion":[50,145],"to":[51,87,102],"eight":[52],"subjects,":[53],"two":[54],"them":[56],"receiving":[57],"placebo.":[58],"Blood":[59],"levels":[60],"measured":[65],"by":[66],"both":[67],"microbiological":[68],"HPLC":[70],"assays.":[71],"At":[72],"the":[73,76,97,113,134,144],"end":[74],"infusion,":[77],"Cmax":[78],"for":[79],"ranged":[82,99],"from":[83,100],"0.95":[84],"+/-":[85,89],"0.22":[86],"24.20":[88],"8.82":[90],"mg/L.":[91],"apparent":[93],"elimination":[94],"half-life":[95],"compound":[98],"1.27":[101],"1.53":[103],"h.":[104],"did":[107],"not":[108],"significantly":[109],"affect":[110],"any":[111],"laboratory":[114],"or":[115,141,152],"clinical":[116,165],"assessments":[117],"(blood":[118],"pressure,":[119],"pulse":[120],"rate,":[121],"ECG,":[122],"peak":[123],"expiratory":[124],"flow":[125],"rate).":[126],"Reported":[127],"adverse":[128],"effects":[129],"mild":[132,139],"intensity;":[133],"most":[135],"frequent":[136],"event":[137],"pain":[140],"burning":[142],"at":[143],"site":[146],"with":[147],"7":[150],"mg/kg":[151],"higher.":[153],"These":[154],"results":[155],"support":[156],"further":[157],"studies":[158],"II":[164],"trials.":[166]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2014,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}